What This Top Dividend Portfolio Is Holding Now: AstraZeneca plc, HSBC Holdings plc And Vodafone Group plc

HSBC Holdings plc (LON:HSBA), AstraZeneca plc (LON:AZN) and Vodafone Group plc (LON:VOD) are heavyweight holdings of JP Morgan Claverhouse Investment Trust (LON:JCH).

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

JP Morgan Claverhouse IT (LSE: JCH) has a record of 41 consecutive years of dividend increases. At a current share price of 582p, the trust is on a trailing yield of 3.4%.

Picking great dividend shares has helped JP Morgan Claverhouse outperform the FTSE All-Share Index over the past three, five and 10 years.

Sectors in which the trust is currently overweight against the index include financials, healthcare and telecoms. The trust’s three biggest holdings in these three sectors are: HSBC (LSE: HSBA) (NYSE: HSBC.US), AstraZeneca (LSE: AZN) and Vodafone (LSE: VOD).

HSBC

Banking giant HSBC may have ditched its advertising slogan “The World’s Local Bank” a couple of years ago, but it has remained a convenient tag for financial hacks like me to emphasise the group’s global reach.

Geographical diversification helped HSBC get through the 2008/9 financial crisis. And while the company did reduce its dividend during those dark days, the payout has been growing at a good clip since, including a 9% rise for 2013.

City analysts are expecting a more modest 4% increase this year, followed by a 7% uplift for 2015. The recent market sell-off has seen HSBC’s shares hit a 52-week low of 589p, pushing the forward dividend yield up to a juicy 5.5% for investors today.

AstraZeneca

It’s been a good year for shareholders of AstraZeneca. The shares, which started the year at 3,600p, are currently trading at 4,427p on the back of the company’s strengthening drugs pipeline and management’s confident rejection of a 5,500p takeover offer from US pharma giant Pfizer.

The improving outlook hasn’t yet fed through to a rising dividend. Analysts are expecting the 2014 payout to be pegged at $2.80 for a fourth consecutive year, and for there to be little, if any, increase in 2015.

Nevertheless, the sterling translation of the dollar dividend equates to a yield of 4%, which is comfortably above the FTSE 100 average of 3.5%. And we could see the payout begin to rise pretty strongly further down the line.

Vodafone

Vodafone has been in a period of transition since selling its stake in US phones firm Verizon Wireless to Verizon Communications for £84bn earlier this year. The mobile giant’s earnings won’t — for at least a couple of years — cover the rising dividends the company hopes to pay.

Nevertheless, management reckons it can afford to lift the annual payouts, and signalled its confidence by raising the company’s recent interim dividend by 2%. If that carries through to the final dividend, as City analysts expect, we’d be looking at a forward yield of around 5.3% at a current share price of 213p.

G A Chester has no position in any shares mentioned. The Motley Fool UK has recommended HSBC Holdings. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Lady wearing a head scarf looks over pages on company financials
Investing Articles

Is April a good time to start buying shares?

Wondering whether now's a good time to start buying shares to build wealth? History suggests it is, says Edward Sheldon.

Read more »

A senior group of friends enjoying rowing on the River Derwent
Investing Articles

How much passive income could a Stocks and Shares ISA pump out every year?

Regular investing inside a Stocks and Shares ISA could lead to the equivalent of £141 a week in tax-free passive…

Read more »

Fans of Warren Buffett taking his photo
Investing Articles

With the FTSE 100 down 5%+ investors should remember this legendary quote from Warren Buffett

Warren Buffett is widely regarded as the greatest investor of all time. And he says that the best time to…

Read more »

Inflation in newspapers
Investing Articles

1 FTSE 100 stock that could benefit from higher inflation

For most companies, inflation is a risk. But for one FTSE 100 firm, higher input costs could be an opportunity…

Read more »

Man hanging in the balance over a log at seaside in Scotland
Investing Articles

The 2026 stock market sell-off could be a rare opportunity to build wealth in an ISA

The recent stock market sell-off has led to some shares falling 20% or more. This could be a great opportunity…

Read more »

Thoughtful man using his phone while riding on a train and looking through the window
Investing Articles

It’s down another 13%! Analysts were dead wrong about the Greggs share price

The Greggs share price continues to fall and analysts have been revising their share price targets down further. Dr James…

Read more »

Burst your bubble thumbtack and balloon background
Investing Articles

Is the stock market about to reach breaking point?

Private credit has a problem with the emergence of artificial intelligence. And it could be set to create issues across…

Read more »

BUY AND HOLD spelled in letters on top of a pile of books. Alongside is a piggy bank in glasses. Buy and hold is a popular long term stock and shares strategy.
Investing Articles

A once-in-a-decade chance to buy this S&P 500 stock?

As investors focus on oil prices and the conflict in Iran, Stephen Wright's looking at potential opportunities in the S&P…

Read more »